搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
Health on MSN
5 小时
What Are Social Cues—and How Do You Understand Them?
Medically reviewed by Michael MacIntyre, MD Social cues allow people to communicate with one another, especially in group ...
The Local
8 小时
Inside Sweden: How a Swedish politician's weird phobia went viral
Another story that went viral this week after The Local was first to cover it, was a Swedish health supplement company ...
The Local
23 小时
Swedish politicians defend banana-phobic minister
Equality minister Paulina Brandberg has revealed that she is 'receiving professional help' for a phobia of bananas, which is ...
1 天
Swedish gender equality minister admits seeking help for 'world's weirdest phobia' of ...
Paulina Brandberg said she is seeking medical treatment for what she has described as 'the world's weirdest phobia' after ...
1 天
I need help for my banana phobia, admits Swedish gender equality minister
A Swedish minister is seeking treatment for her phobia of bananas after it emerged government staff had to sweep rooms before ...
2 天
'Banana-free areas' over Swedish minister's phobia
A Swedish minister's phobia of bananas has reportedly led to government officials asking for rooms to be free of the fruit.
Benzinga.com
3 天
Atai Q3 Report: Strong Cash Position, Clinical Pipeline Growth
Atai plans to begin a Phase 2 study by the end of 2024 to evaluate VLS-01's safety, efficacy and durability in TRD patients. EMP-01 for Social Anxiety Disorder: EMP-01 is an oral R-MDMA formulation ...
dermatologyadvisor
4 天
Primary Hyperhidrosis Is Linked to an Increased Risk for Anxiety, Depression
Adults with primary hyperhidrosis had an increased risk for anxiety and depression when compared with those without primary hyperhidrosis.
6 天
VistaGen Therapeutics’ Promising Clinical Progress and Strong Financial Position Justify ...
Analyst Jason McCarthy of Maxim Group maintained a Buy rating on VistaGen Therapeutics (VTGN – Research Report), retaining the price ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈